nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—Naloxone—TLR4—esophageal cancer	0.0156	0.655	CrCbGaD
Oxycodone—Hydromorphone—PTGS1—esophageal cancer	0.00379	0.16	CrCbGaD
Oxycodone—Naltrexone—ABCB1—esophageal cancer	0.00254	0.107	CrCbGaD
Oxycodone—Stomatitis—Cisplatin—esophageal cancer	0.00241	0.00382	CcSEcCtD
Oxycodone—Hyponatraemia—Capecitabine—esophageal cancer	0.00238	0.00376	CcSEcCtD
Oxycodone—Melaena—Methotrexate—esophageal cancer	0.00237	0.00375	CcSEcCtD
Oxycodone—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00235	0.00372	CcSEcCtD
Oxycodone—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00234	0.00371	CcSEcCtD
Oxycodone—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00234	0.0037	CcSEcCtD
Oxycodone—Migraine—Capecitabine—esophageal cancer	0.00233	0.00369	CcSEcCtD
Oxycodone—Face oedema—Capecitabine—esophageal cancer	0.00228	0.00362	CcSEcCtD
Oxycodone—Bradycardia—Cisplatin—esophageal cancer	0.00226	0.00358	CcSEcCtD
Oxycodone—Irritability—Capecitabine—esophageal cancer	0.00226	0.00357	CcSEcCtD
Oxycodone—Cardiac arrest—Capecitabine—esophageal cancer	0.00225	0.00356	CcSEcCtD
Oxycodone—Urinary retention—Capecitabine—esophageal cancer	0.00225	0.00356	CcSEcCtD
Oxycodone—Mood swings—Capecitabine—esophageal cancer	0.00224	0.00355	CcSEcCtD
Oxycodone—Coma—Methotrexate—esophageal cancer	0.00222	0.00351	CcSEcCtD
Oxycodone—Dehydration—Capecitabine—esophageal cancer	0.0022	0.00348	CcSEcCtD
Oxycodone—Urine output increased—Methotrexate—esophageal cancer	0.00219	0.00347	CcSEcCtD
Oxycodone—Urinary tract disorder—Cisplatin—esophageal cancer	0.00219	0.00347	CcSEcCtD
Oxycodone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00218	0.00345	CcSEcCtD
Oxycodone—Urethral disorder—Cisplatin—esophageal cancer	0.00218	0.00344	CcSEcCtD
Oxycodone—Dry skin—Capecitabine—esophageal cancer	0.00217	0.00343	CcSEcCtD
Oxycodone—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00216	0.00342	CcSEcCtD
Oxycodone—Abdominal pain upper—Capecitabine—esophageal cancer	0.00216	0.00342	CcSEcCtD
Oxycodone—Visual impairment—Cisplatin—esophageal cancer	0.00214	0.00339	CcSEcCtD
Oxycodone—Breast disorder—Capecitabine—esophageal cancer	0.00214	0.00338	CcSEcCtD
Oxycodone—Nasopharyngitis—Capecitabine—esophageal cancer	0.00212	0.00335	CcSEcCtD
Oxycodone—Sepsis—Methotrexate—esophageal cancer	0.00211	0.00333	CcSEcCtD
Oxycodone—Gastritis—Capecitabine—esophageal cancer	0.00209	0.00331	CcSEcCtD
Oxycodone—Eye disorder—Cisplatin—esophageal cancer	0.00208	0.00328	CcSEcCtD
Oxycodone—Tinnitus—Cisplatin—esophageal cancer	0.00207	0.00328	CcSEcCtD
Oxycodone—Lymphadenopathy—Methotrexate—esophageal cancer	0.00206	0.00327	CcSEcCtD
Oxycodone—Flushing—Cisplatin—esophageal cancer	0.00206	0.00326	CcSEcCtD
Oxycodone—Cardiac disorder—Cisplatin—esophageal cancer	0.00206	0.00326	CcSEcCtD
Oxycodone—Abdominal distension—Capecitabine—esophageal cancer	0.00206	0.00326	CcSEcCtD
Oxycodone—Influenza—Capecitabine—esophageal cancer	0.00205	0.00324	CcSEcCtD
Oxycodone—Dysphagia—Capecitabine—esophageal cancer	0.00205	0.00324	CcSEcCtD
Oxycodone—Asthma—Capecitabine—esophageal cancer	0.00205	0.00324	CcSEcCtD
Oxycodone—Thrombophlebitis—Methotrexate—esophageal cancer	0.00204	0.00322	CcSEcCtD
Oxycodone—Bronchospasm—Capecitabine—esophageal cancer	0.00201	0.00318	CcSEcCtD
Oxycodone—Polyuria—Methotrexate—esophageal cancer	0.00201	0.00317	CcSEcCtD
Oxycodone—Immune system disorder—Cisplatin—esophageal cancer	0.00201	0.00317	CcSEcCtD
Oxycodone—Mediastinal disorder—Cisplatin—esophageal cancer	0.002	0.00317	CcSEcCtD
Oxycodone—Bronchitis—Capecitabine—esophageal cancer	0.00197	0.00311	CcSEcCtD
Oxycodone—Malnutrition—Cisplatin—esophageal cancer	0.00193	0.00306	CcSEcCtD
Oxycodone—Dysuria—Capecitabine—esophageal cancer	0.00191	0.00303	CcSEcCtD
Oxycodone—Flatulence—Cisplatin—esophageal cancer	0.00191	0.00301	CcSEcCtD
Oxycodone—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00187	0.00295	CcSEcCtD
Oxycodone—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00187	0.00295	CcSEcCtD
Oxycodone—Muscle spasms—Cisplatin—esophageal cancer	0.00186	0.00294	CcSEcCtD
Oxycodone—Naloxone—ABCB1—esophageal cancer	0.00186	0.0781	CrCbGaD
Oxycodone—Weight decreased—Capecitabine—esophageal cancer	0.00185	0.00293	CcSEcCtD
Oxycodone—Hyperglycaemia—Capecitabine—esophageal cancer	0.00184	0.00292	CcSEcCtD
Oxycodone—Pneumonia—Capecitabine—esophageal cancer	0.00183	0.0029	CcSEcCtD
Oxycodone—Infestation—Capecitabine—esophageal cancer	0.00182	0.00289	CcSEcCtD
Oxycodone—Infestation NOS—Capecitabine—esophageal cancer	0.00182	0.00289	CcSEcCtD
Oxycodone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00182	0.00288	CcSEcCtD
Oxycodone—Tremor—Cisplatin—esophageal cancer	0.00181	0.00287	CcSEcCtD
Oxycodone—Ill-defined disorder—Cisplatin—esophageal cancer	0.00179	0.00284	CcSEcCtD
Oxycodone—Anaemia—Cisplatin—esophageal cancer	0.00179	0.00283	CcSEcCtD
Oxycodone—Stomatitis—Capecitabine—esophageal cancer	0.00178	0.00281	CcSEcCtD
Oxycodone—Urinary tract infection—Capecitabine—esophageal cancer	0.00177	0.00281	CcSEcCtD
Oxycodone—Malaise—Cisplatin—esophageal cancer	0.00174	0.00276	CcSEcCtD
Oxycodone—Haematuria—Capecitabine—esophageal cancer	0.00174	0.00275	CcSEcCtD
Oxycodone—Leukopenia—Cisplatin—esophageal cancer	0.00173	0.00274	CcSEcCtD
Oxycodone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00172	0.00273	CcSEcCtD
Oxycodone—Epistaxis—Capecitabine—esophageal cancer	0.00172	0.00272	CcSEcCtD
Oxycodone—Irritability—Methotrexate—esophageal cancer	0.00168	0.00266	CcSEcCtD
Oxycodone—Convulsion—Cisplatin—esophageal cancer	0.00168	0.00265	CcSEcCtD
Oxycodone—Mood swings—Methotrexate—esophageal cancer	0.00167	0.00264	CcSEcCtD
Oxycodone—Bradycardia—Capecitabine—esophageal cancer	0.00167	0.00264	CcSEcCtD
Oxycodone—Myalgia—Cisplatin—esophageal cancer	0.00165	0.0026	CcSEcCtD
Oxycodone—Haemoglobin—Capecitabine—esophageal cancer	0.00165	0.0026	CcSEcCtD
Oxycodone—Rhinitis—Capecitabine—esophageal cancer	0.00164	0.0026	CcSEcCtD
Oxycodone—Anxiety—Cisplatin—esophageal cancer	0.00164	0.0026	CcSEcCtD
Oxycodone—Haemorrhage—Capecitabine—esophageal cancer	0.00164	0.00259	CcSEcCtD
Oxycodone—Hepatitis—Capecitabine—esophageal cancer	0.00164	0.00259	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00163	0.00259	CcSEcCtD
Oxycodone—Hypoaesthesia—Capecitabine—esophageal cancer	0.00163	0.00258	CcSEcCtD
Oxycodone—Discomfort—Cisplatin—esophageal cancer	0.00163	0.00257	CcSEcCtD
Oxycodone—Pharyngitis—Capecitabine—esophageal cancer	0.00162	0.00257	CcSEcCtD
Oxycodone—Urinary tract disorder—Capecitabine—esophageal cancer	0.00162	0.00256	CcSEcCtD
Oxycodone—Oedema peripheral—Capecitabine—esophageal cancer	0.00161	0.00255	CcSEcCtD
Oxycodone—Connective tissue disorder—Capecitabine—esophageal cancer	0.00161	0.00255	CcSEcCtD
Oxycodone—Urethral disorder—Capecitabine—esophageal cancer	0.0016	0.00254	CcSEcCtD
Oxycodone—Breast disorder—Methotrexate—esophageal cancer	0.00159	0.00252	CcSEcCtD
Oxycodone—Oedema—Cisplatin—esophageal cancer	0.00158	0.0025	CcSEcCtD
Oxycodone—Anaphylactic shock—Cisplatin—esophageal cancer	0.00158	0.0025	CcSEcCtD
Oxycodone—Visual impairment—Capecitabine—esophageal cancer	0.00158	0.0025	CcSEcCtD
Oxycodone—Infection—Cisplatin—esophageal cancer	0.00157	0.00248	CcSEcCtD
Oxycodone—Nervous system disorder—Cisplatin—esophageal cancer	0.00155	0.00245	CcSEcCtD
Oxycodone—Tachycardia—Cisplatin—esophageal cancer	0.00154	0.00244	CcSEcCtD
Oxycodone—Skin disorder—Cisplatin—esophageal cancer	0.00153	0.00243	CcSEcCtD
Oxycodone—Eye disorder—Capecitabine—esophageal cancer	0.00153	0.00242	CcSEcCtD
Oxycodone—Tinnitus—Capecitabine—esophageal cancer	0.00153	0.00242	CcSEcCtD
Oxycodone—Hyperhidrosis—Cisplatin—esophageal cancer	0.00153	0.00241	CcSEcCtD
Oxycodone—Asthma—Methotrexate—esophageal cancer	0.00152	0.00241	CcSEcCtD
Oxycodone—Flushing—Capecitabine—esophageal cancer	0.00152	0.0024	CcSEcCtD
Oxycodone—Cardiac disorder—Capecitabine—esophageal cancer	0.00152	0.0024	CcSEcCtD
Oxycodone—Anorexia—Cisplatin—esophageal cancer	0.0015	0.00238	CcSEcCtD
Oxycodone—Angiopathy—Capecitabine—esophageal cancer	0.00149	0.00235	CcSEcCtD
Oxycodone—Immune system disorder—Capecitabine—esophageal cancer	0.00148	0.00234	CcSEcCtD
Oxycodone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00148	0.00233	CcSEcCtD
Oxycodone—Hypotension—Cisplatin—esophageal cancer	0.00147	0.00233	CcSEcCtD
Oxycodone—Chills—Capecitabine—esophageal cancer	0.00147	0.00232	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00144	0.00227	CcSEcCtD
Oxycodone—Mental disorder—Capecitabine—esophageal cancer	0.00143	0.00227	CcSEcCtD
Oxycodone—Malnutrition—Capecitabine—esophageal cancer	0.00143	0.00226	CcSEcCtD
Oxycodone—Dysuria—Methotrexate—esophageal cancer	0.00142	0.00225	CcSEcCtD
Oxycodone—Paraesthesia—Cisplatin—esophageal cancer	0.00142	0.00224	CcSEcCtD
Oxycodone—Dyspnoea—Cisplatin—esophageal cancer	0.00141	0.00223	CcSEcCtD
Oxycodone—Flatulence—Capecitabine—esophageal cancer	0.0014	0.00222	CcSEcCtD
Oxycodone—Erectile dysfunction—Methotrexate—esophageal cancer	0.0014	0.00222	CcSEcCtD
Oxycodone—Dysgeusia—Capecitabine—esophageal cancer	0.0014	0.00221	CcSEcCtD
Oxycodone—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00139	0.0022	CcSEcCtD
Oxycodone—Back pain—Capecitabine—esophageal cancer	0.00138	0.00218	CcSEcCtD
Oxycodone—Decreased appetite—Cisplatin—esophageal cancer	0.00137	0.00217	CcSEcCtD
Oxycodone—Muscle spasms—Capecitabine—esophageal cancer	0.00137	0.00217	CcSEcCtD
Oxycodone—Pneumonia—Methotrexate—esophageal cancer	0.00137	0.00216	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00136	0.00216	CcSEcCtD
Oxycodone—Infestation NOS—Methotrexate—esophageal cancer	0.00136	0.00215	CcSEcCtD
Oxycodone—Infestation—Methotrexate—esophageal cancer	0.00136	0.00215	CcSEcCtD
Oxycodone—Drowsiness—Methotrexate—esophageal cancer	0.00136	0.00215	CcSEcCtD
Oxycodone—Pain—Cisplatin—esophageal cancer	0.00135	0.00214	CcSEcCtD
Oxycodone—Tremor—Capecitabine—esophageal cancer	0.00134	0.00211	CcSEcCtD
Oxycodone—Stomatitis—Methotrexate—esophageal cancer	0.00132	0.00209	CcSEcCtD
Oxycodone—Ill-defined disorder—Capecitabine—esophageal cancer	0.00132	0.00209	CcSEcCtD
Oxycodone—Anaemia—Capecitabine—esophageal cancer	0.00132	0.00208	CcSEcCtD
Oxycodone—Sweating—Methotrexate—esophageal cancer	0.0013	0.00206	CcSEcCtD
Oxycodone—Feeling abnormal—Cisplatin—esophageal cancer	0.0013	0.00206	CcSEcCtD
Oxycodone—Haematuria—Methotrexate—esophageal cancer	0.00129	0.00205	CcSEcCtD
Oxycodone—Malaise—Capecitabine—esophageal cancer	0.00129	0.00203	CcSEcCtD
Oxycodone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00128	0.00203	CcSEcCtD
Oxycodone—Epistaxis—Methotrexate—esophageal cancer	0.00128	0.00203	CcSEcCtD
Oxycodone—Vertigo—Capecitabine—esophageal cancer	0.00128	0.00203	CcSEcCtD
Oxycodone—Syncope—Capecitabine—esophageal cancer	0.00128	0.00202	CcSEcCtD
Oxycodone—Leukopenia—Capecitabine—esophageal cancer	0.00128	0.00202	CcSEcCtD
Oxycodone—Palpitations—Capecitabine—esophageal cancer	0.00126	0.00199	CcSEcCtD
Oxycodone—Loss of consciousness—Capecitabine—esophageal cancer	0.00125	0.00198	CcSEcCtD
Oxycodone—Body temperature increased—Cisplatin—esophageal cancer	0.00125	0.00197	CcSEcCtD
Oxycodone—Cough—Capecitabine—esophageal cancer	0.00124	0.00197	CcSEcCtD
Oxycodone—Haemoglobin—Methotrexate—esophageal cancer	0.00122	0.00194	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—esophageal cancer	0.00122	0.00193	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—esophageal cancer	0.00122	0.00193	CcSEcCtD
Oxycodone—Chest pain—Capecitabine—esophageal cancer	0.00121	0.00192	CcSEcCtD
Oxycodone—Arthralgia—Capecitabine—esophageal cancer	0.00121	0.00192	CcSEcCtD
Oxycodone—Myalgia—Capecitabine—esophageal cancer	0.00121	0.00192	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—esophageal cancer	0.00121	0.00191	CcSEcCtD
Oxycodone—Anxiety—Capecitabine—esophageal cancer	0.00121	0.00191	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0012	0.00191	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—esophageal cancer	0.0012	0.0019	CcSEcCtD
Oxycodone—Discomfort—Capecitabine—esophageal cancer	0.0012	0.0019	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—esophageal cancer	0.00119	0.00189	CcSEcCtD
Oxycodone—Dry mouth—Capecitabine—esophageal cancer	0.00119	0.00188	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—esophageal cancer	0.00117	0.00186	CcSEcCtD
Oxycodone—Confusional state—Capecitabine—esophageal cancer	0.00117	0.00186	CcSEcCtD
Oxycodone—Oedema—Capecitabine—esophageal cancer	0.00116	0.00184	CcSEcCtD
Oxycodone—Hypersensitivity—Cisplatin—esophageal cancer	0.00116	0.00184	CcSEcCtD
Oxycodone—Infection—Capecitabine—esophageal cancer	0.00116	0.00183	CcSEcCtD
Oxycodone—Shock—Capecitabine—esophageal cancer	0.00114	0.00181	CcSEcCtD
Oxycodone—Nervous system disorder—Capecitabine—esophageal cancer	0.00114	0.0018	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—esophageal cancer	0.00114	0.0018	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—esophageal cancer	0.00114	0.0018	CcSEcCtD
Oxycodone—Tachycardia—Capecitabine—esophageal cancer	0.00114	0.0018	CcSEcCtD
Oxycodone—Asthenia—Cisplatin—esophageal cancer	0.00113	0.00179	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—esophageal cancer	0.00113	0.00179	CcSEcCtD
Oxycodone—Skin disorder—Capecitabine—esophageal cancer	0.00113	0.00179	CcSEcCtD
Oxycodone—Hyperhidrosis—Capecitabine—esophageal cancer	0.00112	0.00178	CcSEcCtD
Oxycodone—Anorexia—Capecitabine—esophageal cancer	0.00111	0.00175	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—esophageal cancer	0.00111	0.00175	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—esophageal cancer	0.0011	0.00174	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—esophageal cancer	0.0011	0.00174	CcSEcCtD
Oxycodone—Chills—Methotrexate—esophageal cancer	0.00109	0.00173	CcSEcCtD
Oxycodone—Hypotension—Capecitabine—esophageal cancer	0.00109	0.00172	CcSEcCtD
Oxycodone—Diarrhoea—Cisplatin—esophageal cancer	0.00108	0.00171	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—esophageal cancer	0.00107	0.00169	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—esophageal cancer	0.00106	0.00168	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00106	0.00168	CcSEcCtD
Oxycodone—Insomnia—Capecitabine—esophageal cancer	0.00105	0.00166	CcSEcCtD
Oxycodone—Paraesthesia—Capecitabine—esophageal cancer	0.00104	0.00165	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—esophageal cancer	0.00104	0.00164	CcSEcCtD
Oxycodone—Dyspnoea—Capecitabine—esophageal cancer	0.00104	0.00164	CcSEcCtD
Oxycodone—Back pain—Methotrexate—esophageal cancer	0.00103	0.00162	CcSEcCtD
Oxycodone—Dyspepsia—Capecitabine—esophageal cancer	0.00102	0.00162	CcSEcCtD
Oxycodone—Decreased appetite—Capecitabine—esophageal cancer	0.00101	0.0016	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.001	0.00159	CcSEcCtD
Oxycodone—Vomiting—Cisplatin—esophageal cancer	0.001	0.00159	CcSEcCtD
Oxycodone—Fatigue—Capecitabine—esophageal cancer	0.001	0.00159	CcSEcCtD
Oxycodone—Rash—Cisplatin—esophageal cancer	0.000995	0.00157	CcSEcCtD
Oxycodone—Constipation—Capecitabine—esophageal cancer	0.000995	0.00157	CcSEcCtD
Oxycodone—Pain—Capecitabine—esophageal cancer	0.000995	0.00157	CcSEcCtD
Oxycodone—Dermatitis—Cisplatin—esophageal cancer	0.000994	0.00157	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000984	0.00156	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—esophageal cancer	0.000981	0.00155	CcSEcCtD
Oxycodone—Feeling abnormal—Capecitabine—esophageal cancer	0.000958	0.00152	CcSEcCtD
Oxycodone—Malaise—Methotrexate—esophageal cancer	0.000957	0.00151	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—esophageal cancer	0.000953	0.00151	CcSEcCtD
Oxycodone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000951	0.0015	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—esophageal cancer	0.00095	0.0015	CcSEcCtD
Oxycodone—Nausea—Cisplatin—esophageal cancer	0.000937	0.00148	CcSEcCtD
Oxycodone—Cough—Methotrexate—esophageal cancer	0.000926	0.00146	CcSEcCtD
Oxycodone—Urticaria—Capecitabine—esophageal cancer	0.000924	0.00146	CcSEcCtD
Oxycodone—Body temperature increased—Capecitabine—esophageal cancer	0.000919	0.00145	CcSEcCtD
Oxycodone—Abdominal pain—Capecitabine—esophageal cancer	0.000919	0.00145	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—esophageal cancer	0.000919	0.00145	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—esophageal cancer	0.000903	0.00143	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—esophageal cancer	0.000903	0.00143	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—esophageal cancer	0.000903	0.00143	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000897	0.00142	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—esophageal cancer	0.000892	0.00141	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—esophageal cancer	0.000873	0.00138	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000866	0.00137	CcSEcCtD
Oxycodone—Infection—Methotrexate—esophageal cancer	0.00086	0.00136	CcSEcCtD
Oxycodone—Hypersensitivity—Capecitabine—esophageal cancer	0.000857	0.00136	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—esophageal cancer	0.000849	0.00134	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—esophageal cancer	0.000841	0.00133	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000837	0.00132	CcSEcCtD
Oxycodone—Asthenia—Capecitabine—esophageal cancer	0.000834	0.00132	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—esophageal cancer	0.000825	0.00131	CcSEcCtD
Oxycodone—Pruritus—Capecitabine—esophageal cancer	0.000823	0.0013	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—esophageal cancer	0.000809	0.00128	CcSEcCtD
Oxycodone—Diarrhoea—Capecitabine—esophageal cancer	0.000796	0.00126	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000789	0.00125	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—esophageal cancer	0.000783	0.00124	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—esophageal cancer	0.000777	0.00123	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—esophageal cancer	0.000772	0.00122	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—esophageal cancer	0.00077	0.00122	CcSEcCtD
Oxycodone—Dizziness—Capecitabine—esophageal cancer	0.000769	0.00122	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—esophageal cancer	0.000762	0.00121	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—esophageal cancer	0.000753	0.00119	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000747	0.00118	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—esophageal cancer	0.000746	0.00118	CcSEcCtD
Oxycodone—Pain—Methotrexate—esophageal cancer	0.00074	0.00117	CcSEcCtD
Oxycodone—Vomiting—Capecitabine—esophageal cancer	0.00074	0.00117	CcSEcCtD
Oxycodone—Rash—Capecitabine—esophageal cancer	0.000733	0.00116	CcSEcCtD
Oxycodone—Dermatitis—Capecitabine—esophageal cancer	0.000733	0.00116	CcSEcCtD
Oxycodone—Headache—Capecitabine—esophageal cancer	0.000729	0.00115	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—esophageal cancer	0.000713	0.00113	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000708	0.00112	CcSEcCtD
Oxycodone—Nausea—Capecitabine—esophageal cancer	0.000691	0.00109	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—esophageal cancer	0.000688	0.00109	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—esophageal cancer	0.000684	0.00108	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—esophageal cancer	0.000684	0.00108	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—esophageal cancer	0.000638	0.00101	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—esophageal cancer	0.000621	0.000983	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—esophageal cancer	0.000613	0.000969	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—esophageal cancer	0.000592	0.000937	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—esophageal cancer	0.000573	0.000906	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—esophageal cancer	0.000551	0.000871	CcSEcCtD
Oxycodone—Rash—Methotrexate—esophageal cancer	0.000546	0.000864	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—esophageal cancer	0.000545	0.000863	CcSEcCtD
Oxycodone—Headache—Methotrexate—esophageal cancer	0.000542	0.000858	CcSEcCtD
Oxycodone—Nausea—Methotrexate—esophageal cancer	0.000514	0.000814	CcSEcCtD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000274	0.000795	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ANXA1—esophageal cancer	0.000273	0.000794	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—WWOX—esophageal cancer	0.000272	0.000789	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—SST—esophageal cancer	0.000266	0.000772	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ELMO1—esophageal cancer	0.000264	0.000768	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADH7—esophageal cancer	0.00026	0.000755	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.00026	0.000755	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.00026	0.000755	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.00026	0.000755	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—GHRL—esophageal cancer	0.000259	0.000752	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000258	0.000751	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKAP13—esophageal cancer	0.000258	0.00075	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PFN1—esophageal cancer	0.000258	0.00075	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000254	0.000739	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—WIF1—esophageal cancer	0.000253	0.000734	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.000248	0.000722	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—SST—esophageal cancer	0.000247	0.000719	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000241	0.0007	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000239	0.000694	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000238	0.000693	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PDE4D—esophageal cancer	0.000236	0.000686	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000236	0.000685	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000233	0.000677	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ELMO1—esophageal cancer	0.000232	0.000673	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000231	0.000671	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000228	0.000662	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKAP13—esophageal cancer	0.000227	0.000658	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000225	0.000653	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GNG7—esophageal cancer	0.000225	0.000653	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—SST—esophageal cancer	0.000225	0.000653	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000222	0.000644	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CA1—esophageal cancer	0.000221	0.000642	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000221	0.000642	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000219	0.000636	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PFN1—esophageal cancer	0.000218	0.000633	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000218	0.000633	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000212	0.000615	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—XIAP—esophageal cancer	0.000211	0.000612	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000209	0.000607	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PDE4D—esophageal cancer	0.000207	0.000602	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000206	0.0006	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CA2—esophageal cancer	0.000202	0.000587	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNA1—esophageal cancer	0.000199	0.000578	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL2—esophageal cancer	0.000198	0.000575	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GNG7—esophageal cancer	0.000197	0.000572	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000197	0.000572	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000197	0.000572	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000196	0.000569	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000191	0.000556	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000189	0.000548	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000188	0.000546	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000188	0.000546	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PSME2—esophageal cancer	0.000185	0.000537	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PSME1—esophageal cancer	0.000185	0.000537	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000185	0.000537	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000185	0.000537	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—XIAP—esophageal cancer	0.000185	0.000536	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ANXA1—esophageal cancer	0.000184	0.000535	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000182	0.000528	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.00018	0.000523	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SST—esophageal cancer	0.000179	0.00052	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000177	0.000513	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000175	0.000509	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNA1—esophageal cancer	0.000175	0.000507	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GHRL—esophageal cancer	0.000175	0.000507	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH3—esophageal cancer	0.000175	0.000507	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL2—esophageal cancer	0.000174	0.000504	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FBXW7—esophageal cancer	0.000172	0.000499	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GNG7—esophageal cancer	0.000171	0.000498	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GNG7—esophageal cancer	0.000167	0.000484	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000165	0.000478	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PSME2—esophageal cancer	0.000162	0.000471	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PSME1—esophageal cancer	0.000162	0.000471	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	0.000161	0.000469	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000161	0.000466	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000157	0.000457	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000157	0.000456	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CA1—esophageal cancer	0.000157	0.000456	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SST—esophageal cancer	0.000157	0.000456	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	0.000157	0.000455	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—XIAP—esophageal cancer	0.000156	0.000453	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000153	0.000445	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GHRL—esophageal cancer	0.000153	0.000444	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	0.000153	0.000444	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000153	0.000444	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000151	0.000438	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	0.000151	0.000437	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000149	0.000433	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000148	0.000429	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000147	0.000426	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CA2—esophageal cancer	0.000144	0.000417	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000143	0.000416	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000143	0.000416	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000142	0.000413	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000142	0.000413	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000141	0.00041	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000141	0.00041	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	0.000139	0.000403	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	0.000137	0.000399	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PSME1—esophageal cancer	0.000137	0.000398	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PSME2—esophageal cancer	0.000137	0.000398	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000136	0.000396	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000136	0.000396	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000134	0.000388	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000134	0.000388	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SST—esophageal cancer	0.000133	0.000385	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	0.000131	0.000382	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000131	0.000382	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.00013	0.000378	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GHRL—esophageal cancer	0.000129	0.000376	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000129	0.000376	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000127	0.00037	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000124	0.00036	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	0.000122	0.000354	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000122	0.000353	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000121	0.000351	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000121	0.000351	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000117	0.00034	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000116	0.000337	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000116	0.000337	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	0.000115	0.000335	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.000114	0.000332	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000112	0.000325	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.00011	0.000321	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000109	0.000317	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000109	0.000316	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	0.000108	0.000312	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000106	0.000308	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMOX1—esophageal cancer	0.000104	0.000303	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000103	0.0003	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000103	0.0003	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	0.000103	0.000299	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KDR—esophageal cancer	0.000103	0.000299	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CA1—esophageal cancer	0.000103	0.000298	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000103	0.000298	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PSME2—esophageal cancer	0.000102	0.000296	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PSME1—esophageal cancer	0.000102	0.000296	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000101	0.000294	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000101	0.000294	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ABCB1—esophageal cancer	0.0001	0.000291	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	9.74e-05	0.000283	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.71e-05	0.000282	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	9.69e-05	0.000281	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	9.43e-05	0.000274	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CA2—esophageal cancer	9.39e-05	0.000273	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GAPDH—esophageal cancer	9.34e-05	0.000271	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.26e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KDR—esophageal cancer	9.02e-05	0.000262	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GNG7—esophageal cancer	8.81e-05	0.000256	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.79e-05	0.000255	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	8.78e-05	0.000255	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.73e-05	0.000254	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADH7—esophageal cancer	8.73e-05	0.000254	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	8.63e-05	0.000251	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	8.5e-05	0.000247	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP19A1—esophageal cancer	8.27e-05	0.00024	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.25e-05	0.00024	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	8.25e-05	0.00024	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	7.97e-05	0.000232	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOS3—esophageal cancer	7.87e-05	0.000228	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.85e-05	0.000228	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.76e-05	0.000225	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	7.7e-05	0.000224	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.66e-05	0.000222	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—esophageal cancer	7.62e-05	0.000221	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	7.57e-05	0.00022	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.55e-05	0.000219	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	7.49e-05	0.000218	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	7.36e-05	0.000214	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.36e-05	0.000214	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO1—esophageal cancer	7.36e-05	0.000214	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMP—esophageal cancer	7.32e-05	0.000213	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSME2—esophageal cancer	7.25e-05	0.000211	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSME1—esophageal cancer	7.25e-05	0.000211	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCB1—esophageal cancer	7.24e-05	0.00021	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	7.23e-05	0.00021	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	7.18e-05	0.000209	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.12e-05	0.000207	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.94e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOS3—esophageal cancer	6.9e-05	0.0002	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.7e-05	0.000194	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.62e-05	0.000192	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TPI1—esophageal cancer	6.62e-05	0.000192	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	6.57e-05	0.000191	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	6.51e-05	0.000189	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—esophageal cancer	6.5e-05	0.000189	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	6.45e-05	0.000187	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	6.4e-05	0.000186	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.35e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	6.29e-05	0.000183	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.25e-05	0.000182	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	6.11e-05	0.000178	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.11e-05	0.000177	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.05e-05	0.000176	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NOS3—esophageal cancer	6e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EP300—esophageal cancer	5.98e-05	0.000174	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.88e-05	0.000171	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOS3—esophageal cancer	5.83e-05	0.000169	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNG7—esophageal cancer	5.76e-05	0.000167	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—esophageal cancer	5.7e-05	0.000166	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	5.55e-05	0.000161	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	5.51e-05	0.00016	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.48e-05	0.000159	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	5.45e-05	0.000158	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.4e-05	0.000157	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.37e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EP300—esophageal cancer	5.25e-05	0.000152	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—esophageal cancer	5.21e-05	0.000151	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.15e-05	0.00015	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.13e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—esophageal cancer	5.1e-05	0.000148	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.07e-05	0.000147	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.84e-05	0.000141	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—esophageal cancer	4.82e-05	0.00014	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO1—esophageal cancer	4.81e-05	0.00014	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.81e-05	0.00014	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSME1—esophageal cancer	4.74e-05	0.000138	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSME2—esophageal cancer	4.74e-05	0.000138	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	4.66e-05	0.000135	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—esophageal cancer	4.57e-05	0.000133	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—EP300—esophageal cancer	4.56e-05	0.000132	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—esophageal cancer	4.47e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EP300—esophageal cancer	4.43e-05	0.000129	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	4.43e-05	0.000129	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NOS3—esophageal cancer	4.33e-05	0.000126	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—esophageal cancer	4.28e-05	0.000124	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.09e-05	0.000119	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.96e-05	0.000115	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	3.88e-05	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—esophageal cancer	3.86e-05	0.000112	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.84e-05	0.000112	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—esophageal cancer	3.78e-05	0.00011	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—esophageal cancer	3.75e-05	0.000109	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.51e-05	0.000102	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.44e-05	0.0001	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.37e-05	9.8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.37e-05	9.78e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—EP300—esophageal cancer	3.3e-05	9.58e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	3.28e-05	9.53e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—esophageal cancer	3.17e-05	9.22e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NOS3—esophageal cancer	3.08e-05	8.95e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.82e-05	8.19e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.44e-05	7.08e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—EP300—esophageal cancer	2.34e-05	6.81e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.25e-05	6.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NOS3—esophageal cancer	2.01e-05	5.85e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.84e-05	5.35e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.73e-05	5.04e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EP300—esophageal cancer	1.53e-05	4.45e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.13e-05	3.29e-05	CbGpPWpGaD
